Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation
Li Chen(Lishui University), Jiansong Ji(Wenzhou Medical University), Tu Jianfei(Lishui University), Linqiang Lai(Lishui University), Fazong Wu(Wenzhou Medical University), Dengke Zhang(Wenzhou Medical University), Xihui Ying(Lishui Central Hospital)
Cited by 12
Related Papers
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
|Cell Communication and Signaling|2020|232
Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
|Scientific Reports|2016|143
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
|Journal of Experimental & Clinical Cancer Research|2020|107